Latest News & Features
Americas
Nexus Pharmaceuticals is knocked back by the US Court of Appeals, which upholds a district court finding that it infringed a rival’s patents. 8 June 2026
Careers
Known for his work on major pharmaceutical patent disputes and landmark SEP cases, the London-based litigator has joined a new firm as partner. 8 June 2026
Americas
Justices refuse to place generic drug makers “between a rock and a hard place,” in a landmark ruling clarifying induced patent infringement in pharma. 4 June 2026
Biotechnology
The deal gives Pfizer access to 12 early-stage oncology programmes and marks the latest in a growing wave of high-value licensing agreements between Big Pharma and Chinese biotechs. 4 June 2026
Careers
The new recruit, who will also support the firm’s UPC practice, brings more than 25 years’ experience and a “strong track record of handling technically and legally complex disputes” in the UK. 4 June 2026
Careers
The Indian firm has added a partner who brings more than three decades of experience advising clients across the pharmaceuticals, life sciences, technology and manufacturing sectors. 4 June 2026
Americas
A district court has thrown out one challenge over the vaccine delivery technology, while a separate appeal could affect protections available to government contractors during national emergencies. 3 June 2026
Europe
The court has officially opened its mediation and arbitration forum, with technology, life sciences and manufacturing companies expected to be among its earliest users—particularly in FRAND and licensing cases. 2 June 2026
Americas
A district jury has handed a J&J unit a clean sweep in its defence against a rival's heart pump patent claims, delivering a win under the seldom-invoked reverse doctrine of equivalents. 1 June 2026
Careers
The new hire brings nearly two decades of trial experience in complex disputes across patents, trademarks, copyright and confidential information, including landmark patent litigation before the UK Supreme Court. 1 June 2026